Company Monitoring Page for Allergan

latest headlines for company on cafepharma

Allergan's Vraylar launch a success, despite trial failure
BioPharma Dive
Tue, 08/9/16 - 10:40 am
Tags:
Allergan, Vraylar, drug launches, clinical trials, antipsychotics, Geodon Richter
Allergan revenue disappoints as Alzheimer drug loses exclusivity
Yahoo/Reuters
Mon, 08/8/16 - 10:04 am
Tags:
Allergan, earnings, Namenda XR
Business groups sue U.S. gov over tax rules that spoiled 'Pfizergan'
Fierce Pharma
Mon, 08/8/16 - 10:00 am
Tags:
taxes, Pfizer, Allergan, M&A
Allergan's cash-use plan, pipeline could add to share run
Yahoo/Reuters
Thu, 08/4/16 - 09:18 pm
Tags:
Allergan
Will Merck Pay A 29% Premium for Biogen?
Forbes
Thu, 08/4/16 - 10:02 am
Tags:
Biogen, Merck, Allergan, M&A
Teva Pharm to focus on integrating Allergan's generics business
Yahoo/Reuters
Thu, 08/4/16 - 09:57 am
Tags:
Teva Pharmaceuticals, generics, M&A, Allergan
Biogen: Allergan or Merck? Neither
Barron's
Thu, 08/4/16 - 09:49 am
Tags:
Biogen, M&A, Merck, Allergan
Teva to buy Allergan's Anda Inc. distribution business for $500 mln
Marketwatch
Wed, 08/3/16 - 09:22 am
Tags:
Teva Pharmaceutical, Anda, Allergan, M&A
Merck and Allergan have both expressed interest in a Biogen takeover
Marketwatch
Tue, 08/2/16 - 03:12 pm
Tags:
Merck, Allergan, Biogen, M&A
Ex-Allergan CEO David Pyott backs a biotech startup alongside Takeda, PhI trial set to launch
Endpoints
Mon, 08/1/16 - 09:44 am
Tags:
Allergan, David Pyott, biotech, Takeda, Bioniz, peptide platform
The Shire Vs. Allergan War Has Begun
Seeking Alpha
Mon, 08/1/16 - 09:39 am
Tags:
Shire, Allergan, dry eye disease, Xiidra, Restasis
FTC Clears Teva Pharmaceutical Industries-Allergan plc Generics Deal; What's Next?
Bidness, ETC
Sat, 07/30/16 - 09:45 pm
Tags:
FTC, Teva Pharmaceuticals, Allergan, generics
Shire targets Allergan's dry-eye market share by pricing Xiidra at $5K per year--right on par with Restasis
Fierce Pharma
Tue, 07/26/16 - 11:25 am
Tags:
dry eye disease, Shire, Allergan, Xiidra, Restasis
Six Major Biotech Acquisitions You Could See in 2016 (Part 2)
Forbes
Mon, 07/25/16 - 09:51 am
Tags:
biotech, M&A, Pfizer, Teva Pharmaceutical, Allergan, Shire, Portola Pharmaceuticals, Sanofi, Medivation, Regeneron, Biogen
Amgen and Allergan Study Finds Biosimilar Comparable to Herceptin
WSJ Online
Fri, 07/22/16 - 09:49 am
Tags:
Amgen, Allergan, biosimilars, Herceptin, ABP 980, Roche, breast cancer
Allergan asks FDA to approve Oculeve neurostim device
Mass Device
Mon, 07/18/16 - 11:03 am
Tags:
Allergan, FDA, Oculeve, neurostimulation, devices
Why Allergan thinks an 'open science' approach can help it develop new antibiotics
BioPharma Dive
Fri, 07/15/16 - 10:16 am
Tags:
Allergan, R&D, antibiotics, open science
Teva, Allergan generics deal to close 'at any time now'
BioPharma Dive
Thu, 07/14/16 - 10:08 am
Tags:
Teva Pharmaceutical, generics, M&A, Allergan
Teva Pharm to raise $20-$25 bln in bond sale next week -report
Yahoo/Reuters
Thu, 07/14/16 - 09:13 am
Tags:
Teva Pharmaceutical, Allergan, M&A, generics, bonds
Should Allergan Worry About Shire’s Win With Dry Eye Drug?
Bidness, ETC
Wed, 07/13/16 - 11:02 am
Tags:
Allergan, Shire, dry eye disease, Restasis, Xiidra

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.